title: Classifying the additional morbidities of Gaucher disease.
authors.affiliation: Center for Lysosomal and Metabolic Diseases and Division of Pharmacology, Vascular and Metabolic Diseases, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands; Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands. Electronic address: m.langeveld@amc.uva.nl.
authors.forename: Mirjam
authors.initials: M
authors.lastname: Langeveld
authors.affiliation: Gaucher Clinic, Department of Medicine, Shaare Zedek Medical Center, Hebrew University and Hadassah Medical School, Jerusalem, Israel.
authors.forename: Deborah
authors.initials: D
authors.lastname: Elstein
authors.affiliation: Clinical Haematology and Bone Marrow Transplant Service, Royal Melbourne Hospital, Parkville, Victoria, Australia.
authors.forename: Jeff
authors.initials: J
authors.lastname: Szer
authors.affiliation: Department of Endocrinology and Metabolism, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: Carla E M
authors.initials: CEM
authors.lastname: Hollak
authors.affiliation: Gaucher Clinic, Department of Medicine, Shaare Zedek Medical Center, Hebrew University and Hadassah Medical School, Jerusalem, Israel.
authors.forename: Ari
authors.initials: A
authors.lastname: Zimran
mesh_terms: D015897:Comorbidity; D056947:Enzyme Replacement Therapy / Q000009:adverse effects; D005776:Gaucher Disease / Q000150:complications* / Q000188:drug therapy; D006801:Humans